Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-07

Clinical Trial Update: Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study

View source ↗

Summary

A prospective observational study in Korean patients with dyslipidemia to assess the efficacy and safety of Baroezet Tablet; the study status is NOT_YET_RECRUIT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baroezet Tablet

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Dyslipidemia | Status: NOT_YET_RECRUITING